T1	SectionAnnotate 208 235	HISTORY OF PRESENT ILLNESS:
T2	SectionAnnotate 2118 2135	Review of Systems
T3	SectionSkip 3197 3211	Physical Exam:
T4	SectionSkip 3651 3828	Physical Exam  Vitals signs and nursing note reviewed.   Constitutional:       General: He is not in acute distress.     Appearance: He is well-developed. He is not diaphoretic.
T5	SectionSkip 4870 5105	Findings: No rash.   Neurological:      Mental Status: He is alert and oriented to person, place, and time.      Cranial Nerves: No cranial nerve deficit.      Motor: No abnormal muscle tone.      Deep Tendon Reflexes: Reflexes normal.
 mutational burden = 5 Muts/Mb  KRAS G12V  TP53 I195F  VUS:   CBL P782L  CDKN2A/B loss  MTOR  R2109  NKX2-1 G239_G241del  PDGFRB  V523M  PIK3C2G  T488A  TNFAIP3  P752S    Imaging Results:  No recent imaging reviewed     Assessment/Plan    ***** ***** is a 58 y.o. male with locally advanced pMMR pancreatic cancer.    Patient is s/p 8 cycles of FOLFIRINOX and now on chemotherapy break since 11/06/18. He continues to do clinically well. Patient prefers to hold off on any additional imaging for now and agrees to return to see me in June. Agrees to complete a new CT CAP in July 2019.    RTC: June 2019    ***** spent a total of 25 minutes face-to-face with the patient and >50% of that time was spent counseling regarding the symptoms, treatment plan, and therapeutic options for the diagnoses above.    ***** *****, NP
T7	PROBLEM 81 123	locally advanced pancreatic adenocarcinoma
T8	PROBLEM 252 260	abd pain
T9	TEST 288 305	A first endoscopy
T10	PROBLEM 316 356	abnormalities in the stomach or duodenum
T11	TEST 361 371	Ultrasound
T12	PROBLEM 379 401	pancreatic tail lesion
T13	TEST 414 421	CT scan
T14	PROBLEM 456 516	locally advanced pancreatic cancer.Pancreatic body/tail mass
T15	TEST 557 618	an endoscopic ultrasound guided biopsy of the pancreatic tail
T16	PROBLEM 632 646	adenocarcinoma
T17	TREATMENT 733 745	chemotherapy
T18	TREATMENT 775 802	any active cancer treatment
T19	TREATMENT 829 853	nutritional optimization
T20	TEST 874 876	CT
T21	PROBLEM 884 908	Slight interval increase
T22	PROBLEM 920 962	locally advanced pancreatic adenocarcinoma
T23	PROBLEM 1018 1069	new focal occlusion of SMV-portal venous confluence
T24	TEST 1109 1111	CT
T25	PROBLEM 1150 1173	slightly increased size
T26	PROBLEM 1177 1211	a locally advanced pancreatic mass
T27	PROBLEM 1217 1245	similar vascular involvement
T28	PROBLEM 1250 1281	unchanged thrombosis of the SMV
T29	PROBLEM 1326 1358	intrathoracic metastatic disease
T30	TEST 1374 1394	the 07/03/18 CT scan
T31	TREATMENT 1431 1443	chemotherapy
T32	TREATMENT 1474 1483	treatment
T33	TreatmentType 1530 1539	treatment
T34	TEST 1631 1633	CT
T35	PROBLEM 1634 1678	CAP slight interval decrease in size of mass
T36	PROBLEM 1761 1768	fatigue
T37	TREATMENT 1821 1831	irinotecan
T38	TEST 1844 1846	CT
T39	PROBLEM 1854 1868	stable disease
T40	TREATMENT 1898 1918	a chemotherapy break
T41	TEST 1932 1934	CT
T42	PROBLEM 1943 1957	stable disease
T43	PROBLEM 2064 2097	intermittent upper abdominal pain
T44	Symptom 2167 2173	chills
T45	Symptom 2175 2186	diaphoresis
T46	Symptom 2188 2195	fatigue
T47	Symptom 2197 2202	fever
T48	Symptom 2207 2231	unexpected weight change
T49	Symptom 2256 2260	lump
T50	Symptom 2261 2265	mass
T51	Symptom 2267 2278	sore throat
T52	Symptom 2283 2301	trouble swallowing
T53	Symptom 2325 2332	icterus
T54	Symptom 2362 2372	hemoptysis
T55	Symptom 2377 2385	wheezing
T56	Symptom 2419 2431	leg swelling
T57	PROBLEM 2466 2480	abdominal pain
T58	Symptom 2495 2509	blood in stool
T59	Symptom 2511 2523	constipation
T60	Symptom 2525 2533	diarrhea
T61	Symptom 2535 2541	nausea
T62	Symptom 2546 2554	vomiting
T63	Symptom 2586 2595	frequency
T64	Symptom 2597 2606	hematuria
T65	Symptom 2611 2622	pelvic pain
T66	Symptom 2668 2677	back pain
T67	Symptom 2679 2687	myalgias
T68	Symptom 2692 2706	neck stiffness
T69	Symptom 2729 2736	itching
T70	Symptom 2741 2745	rash
T71	Symptom 2776 2785	dizziness
T72	Symptom 2787 2805	extremity weakness
T73	Symptom 2810 2818	numbness
T74	Symptom 2857 2869	bruise/bleed
T75	Symptom 2928 2938	depression
T76	Symptom 2943 2960	sleep disturbance
T77	TEST 2964 2981	All other systems
T78	PROBLEM 3036 3055	Patient's allergies
T79	TREATMENT 3057 3068	medications
T80	TEST 3246 3249	BSA
T81	TEST 3272 3278	Vitals
T82	TEST 3299 3301	BP
T83	PROBLEM 3368 3385	ABNORMAL SYMPTOMS
T84	TEST 3388 3392	Resp
T85	TEST 3399 3403	Temp
T86	TEST 3410 3411	C
T87	TEST 3423 3430	TempSrc
T88	TEST 3432 3447	Temporal   SpO2
T89	TEST 3456 3462	Weight
T90	TEST 3490 3496	Height
T91	TEST 3666 3678	Vitals signs
T92	PROBLEM 3752 3766	acute distress
T93	PROBLEM 3816 3827	diaphoretic
T94	PROBLEM 3887 3897	atraumatic
T95	PROBLEM 3999 4014	scleral icterus
T96	PROBLEM 4036 4045	discharge
T97	PROBLEM 4169 4172	JVD
T98	PROBLEM 4191 4209	tracheal deviation
T99	PROBLEM 4326 4332	murmur
T100	PROBLEM 4337 4349	friction rub
T101	PROBLEM 4408 4428	respiratory distress
T102	TEST 4435 4448	Breath sounds
T103	PROBLEM 4475 4482	stridor
T104	PROBLEM 4487 4495	wheezing
T105	PROBLEM 4499 4504	rales
T106	PROBLEM 4604 4608	mass
T107	PROBLEM 4615 4625	Tenderness
T108	PROBLEM 4639 4649	tenderness
T109	PROBLEM 4663 4671	guarding
T110	PROBLEM 4678 4684	Hernia
T111	PROBLEM 4689 4695	hernia
T112	PROBLEM 4833 4843	tenderness
T113	PROBLEM 4847 4856	deformity
T114	PROBLEM 4883 4887	rash
T115	PROBLEM 5002 5023	cranial nerve deficit
T116	PROBLEM 5040 5060	abnormal muscle tone
T117	TEST 5067 5087	Deep Tendon Reflexes
T118	TEST 5152 5161	WBC Count
T119	TEST 5180 5190	Hemoglobin
T120	TEST 5210 5220	Hematocrit
T121	TEST 5227 5228	L
T122	TEST 5244 5258	Platelet Count
T123	TEST 5277 5287	Neutrophil
T124	TEST 5288 5302	Absolute Count
T125	TEST 5322 5342	Alanine transaminase
T126	TEST 5360 5382	Aspartate transaminase
T127	TEST 5404 5424	Alkaline Phosphatase
T128	TEST 5442 5451	Bilirubin
T129	TEST 5453 5458	Total
T130	TEST 5477 5482	Int'l
T131	TEST 5483 5491	Normaliz
T132	TEST 5492 5497	Ratio
T133	TEST 5516 5540	Carcinoembryonic Antigen
T134	TEST 5564 5588	Carcinoembryonic Antigen
T135	TEST 5612 5636	Carcinoembryonic Antigen
T136	TEST 5660 5674	Cancer Antigen
T137	TEST 5702 5716	Cancer Antigen
T138	TEST 5746 5760	Cancer Antigen
T139	TEST 5791 5808	Molecular testing
T140	PROBLEM 5853 5878	Tumor 
 mutational burden
T141	TEST 5883 5896	Muts/Mb  KRAS
T142	TEST 5903 5909	TP53 I
T143	TEST 5915 5918	VUS
T144	TEST 5922 5925	CBL
T145	PROBLEM 5933 5939	CDKN2A
T146	TEST 5948 5952	MTOR
T147	TEST 5961 5967	NKX2-1
T148	TEST 6031 6038	Imaging
T149	TEST 6052 6066	recent imaging
T150	PROBLEM 6134 6174	locally advanced pMMR pancreatic cancer.
T151	TREATMENT 6205 6215	FOLFIRINOX
T152	TREATMENT 6227 6245	chemotherapy break
T153	TEST 6329 6351	any additional imaging
T154	TEST 6419 6431	a new CT CAP
T155	PROBLEM 6584 6596	the symptoms
T156	TREATMENT 6598 6612	treatment plan
T6	Age 63 69	58 y.o
T157	ClinicalCondition 98 123	pancreatic adenocarcinoma
T158	Histology 109 123	adenocarcinoma
A1	ContinuityVal T157 stable
A2	EpisodeDescription T158 Others
T159	Stage 81 97	locally advanced
A3	HistoryVal T159 history
A4	EpisodeDescription T159 Others
A5	HistoryVal T158 history
R1	TumorDesc TumorDetails:T159 Desc:T157	
R2	TumorDesc TumorDetails:T158 Desc:T157	
T160	Datetime 238 250	October 2017
T161	Symptom 252 260	abd pain
A6	IsPresentOnFirstCancerDiagnosis T161 yes
A7	IsCausedByDiagnosedCancer T161 yes
A8	ChronicVal T161 non-chronic
R3	HappensAtOnDuring Arg1:T161 Arg2:T160	
T162	ProcedureName 296 305	endoscopy
A9	IntentVal T162 diagnosis
A10	TreatmentTypeVal T162 others
A11	TreatmentCategory T162 Others
R4	TestOrProcedureConductedForProblem Test:T162 Prob:T161	
T163	ClinicalCondition 313 329	no abnormalities
A12	RadPathResultVal T163 NoDisease
T164	Site 337 344	stomach
T165	Site 348 356	duodenum
R5	SiteOf Arg1:T164 Arg2:T163	
R6	SiteOf Arg1:T165 Arg2:T163	
T166	ProcedureName 361 371	Ultrasound
A13	IntentVal T166 diagnosis
A14	TreatmentTypeVal T166 others
A15	TreatmentCategory T166 Others
T167	RadPathResult 395 401	lesion
T168	Site 379 394	pancreatic tail
R8	SiteOf Arg1:T168 Arg2:T167	
R10	TestOrProcedureReveals Test:T162 Desc:T163	
R7	HappensAfter Arg1:T162 Arg2:T160	
R11	HappensAfter Arg1:T166 Arg2:T160	
T169	Radiology 414 421	CT scan
A17	IntentVal T169 diagnosis
T170	Datetime 435 448	December 2017
T171	Stage 456 472	locally advanced
A18	HistoryVal T171 new
A19	EpisodeDescription T171 FirstOccurrence
T172	RadPathResult 473 490;512 516	pancreatic cancer mass
A20	ContinuityVal T172 new
R12	TumorDesc TumorDetails:T171 Desc:T172	
R14	HappensAtOnDuring Arg1:T169 Arg2:T170	
T174	Site 491 511	Pancreatic body/tail
T175	Size 527 545	4.8 x 2.5 x 2.8 cm
A22	HistoryVal T175 new
A23	EpisodeDescription T175 FirstOccurrence
T176	ProcedureName 560 595	endoscopic ultrasound guided biopsy
A24	IntentVal T176 diagnosis
A25	TreatmentTypeVal T176 others
A26	TreatmentCategory T176 AntiNeoPlastics
T177	Histology 632 646	adenocarcinoma
A27	HistoryVal T177 new
A28	EpisodeDescription T177 FirstOccurrence
T178	Site 603 618	pancreatic tail
T179	BiomarkerName 649 652	MMR
A29	HistoryVal T179 new
A30	EpisodeDescription T179 FirstOccurrence
T180	BiomarkerResult 648 649	p
A31	EpisodeDescription T180 FirstOccurrence
A32	BiomarkerResultVal T180 Negative
R20	BiomarkerRel Arg1:T180 Arg2:T179	
T181	ClinicalCondition 603 613;632 646	pancreatic adenocarcinoma
A33	ContinuityVal T181 new
R21	TumorDesc TumorDetails:T179 Desc:T181	
R18	SiteOf Arg1:T178 Arg2:T181	
R19	TumorDesc TumorDetails:T177 Desc:T181	
R22	TumorDesc TumorDetails:T179 Desc:T181	
R23	TestOrProcedureReveals Test:T176 Desc:T181	
T182	Radiology 874 882	CT C/A/P
A34	IntentVal T182 others
T183	Datetime 864 872	04/17/18
R25	HappensAtOnDuring Arg1:T182 Arg2:T183	
T184	RadPathResult 884 919	Slight interval increase in size of
A35	RadPathResultVal T184 Progression
T185	RadPathResult 937 962	pancreatic adenocarcinoma
A36	ContinuityVal T185 worsening
T186	Histology 948 962	adenocarcinoma
A37	EpisodeDescription T186 Progression
R26	TumorDesc TumorDetails:T186 Desc:T185	
T187	Stage 920 936	locally advanced
A38	EpisodeDescription T187 Progression
R27	TumorDesc TumorDetails:T187 Desc:T185	
A39	RadPathResultVal T172 InitialCancerDiagnosis
R13	SiteOf Arg1:T174 Arg2:T172	
R15	SizeOf Arg1:T175 Arg2:T172	
R16	ResultOfTest Desc:T172 Test:T169	
A21	RadPathResultVal T185 Progression
R17	ResultOfTest Desc:T184 Test:T182	
T173	RadPathResult 1022 1037	focal occlusion
A40	RadPathResultVal T173 Progression
R24	ResultOfTest Desc:T173 Test:T182	
T188	Datetime 1072 1080	04/17/18
T189	DiagnosticLabTest 1081 1088	CA 19-9
A41	IntentVal T189 others
T190	LabTestResult 1089 1095	72,710
A42	LabTestResultVal T190 abnormal
R28	ResultOfTest Desc:T190 Test:T189	
R29	HappensAtOnDuring Arg1:T189 Arg2:T188	
T191	Datetime 1099 1107	07/03/18
T192	Radiology 1109 1117	CT C/A/P
A43	IntentVal T192 others
T193	RadPathResult 1137 1178;1207 1321	Questionable slightly increased size of a mass with similar vascular involvement and unchanged thrombosis of the SMV-portal vein confluence and splenic vein
A44	NegationModalityVal T193 uncertain_in_present
A45	RadPathResultVal T193 Progression
T194	Stage 1179 1195	locally advanced
A46	NegationModalityVal T194 uncertain_in_present
A47	EpisodeDescription T194 Progression
T195	Site 1196 1206	pancreatic
R30	SiteOf Arg1:T195 Arg2:T193	
T196	RadPathResult 1323 1325;1340 1358	No metastatic disease
A48	RadPathResultVal T196 NoDisease
T197	Site 1326 1339	intrathoracic
R31	SiteOf Arg1:T197 Arg2:T196	
R32	ResultOfTest Desc:T196 Test:T192	
R33	ResultOfTest Desc:T193 Test:T192	
R34	TestOrProcedureReveals Test:T192 Desc:T194	
T198	TreatmentType 1431 1443	chemotherapy
A49	NegationModalityVal T198 negated
T199	Datetime 1378 1386	07/03/18
R35	HappensAfter Arg1:T198 Arg2:T199	
T200	TreatmentType 733 745	chemotherapy
A50	NegationModalityVal T200 negated
T201	Datetime 657 665	01/02/18
R36	HappensAtOnDuring Arg1:T200 Arg2:T201	
T202	Datetime 1922 1930	02/02/19
T203	Radiology 1932 1934	CT
A51	IntentVal T203 TreatmentAssessment
T204	RadPathResult 1943 1957	stable disease
A52	RadPathResultVal T204 DiseaseStability
R37	ResultOfTest Desc:T204 Test:T203	
R38	HappensAtOnDuring Arg1:T203 Arg2:T202	
T205	PhysicalActivity 2018 2028	exercising
T206	Symptom 2033 2044	eating well
A53	NegationModalityVal T206 negated
T207	Symptom 2064 2097	intermittent upper abdominal pain
A54	IsPresentOnFirstCancerDiagnosis T207 yes
A55	IsCausedByDiagnosedCancer T207 yes
A56	ChronicVal T207 non-chronic
A57	ContinuityVal T207 stable
T208	Symptom 2466 2480	abdominal pain
A58	IsPresentOnFirstCancerDiagnosis T208 yes
A59	IsCausedByDiagnosedCancer T208 yes
A60	ChronicVal T208 non-chronic
A61	ContinuityVal T208 stable
T209	Age 6116 6123	58 y.o.
T210	ClinicalCondition 6156 6173	pancreatic cancer
T211	BiomarkerName 6152 6155	MMR
T212	BiomarkerResult 6151 6152	p
R39	BiomarkerRel Arg1:T212 Arg2:T211	
R40	TumorDesc TumorDetails:T211 Desc:T210	
T213	Stage 6134 6150	locally advanced
R41	TumorDesc TumorDetails:T213 Desc:T210	
A62	ContinuityVal T210 stable
T214	MedicationRegimen 6205 6215	FOLFIRINOX
A63	TreatmentContinuityVal T214 finished
A64	TreatmentTypeVal T214 maintenance
T215	Cycles 6193 6201	8 cycles
R42	TreatmentDesc Therapy:T215 Desc:T214	
T216	TreatmentType 6227 6245	chemotherapy break
A65	TreatmentTypeVal T216 others
T217	Datetime 6252 6260	11/06/18
R43	HappensAfter Arg1:T216 Arg2:T217	
T218	Radiology 6425 6431	CT CAP
A66	NegationModalityVal T218 planned_in_future
A67	IntentVal T218 TreatmentAssessment
T219	Datetime 6435 6444	July 2019
R44	HappensAtOnDuring Arg1:T218 Arg2:T219	
T220	SectionSkip 3185 3637;3651 3914;3917 5105	Objective   Physical Exam:  Vital Signs for this encounter:  BSA: 1.95 meters squared  Vitals:    05/07/19 0939   BP: 143/71  Comment: ALL VST FROM *****   Pulse: (!) 49  Comment: NO ABNORMAL SYMPTOMS   Resp: 18   Temp: 37.6 C (99.7 F)   TempSrc: Temporal   SpO2: 100%   Weight: 77.8 kg (171 lb 9.6 oz)   Height: 175.4 cm (5' 9.06")  Comment: December 01@*****   PainSc:   5   PainLoc: Abdomen  Comment: STOMACH, PANCREAS AREA       Performance Status: Physical Exam  Vitals signs and nursing note reviewed.   Constitutional:       General: He is not in acute distress.     Appearance: He is well-developed. He is not diaphoretic.      Comments: +Thin   HENT:      Head: Normocephalic and atraumatic.      Right Ear: External ear normal.      Left Ear: External ear normal.   Eyes:      General: No scleral icterus.        Left eye: No discharge.      Pupils: Pupils are equal, round, and reactive to light.   Neck:      Musculoskeletal: Neck supple.      Vascular: No JVD.      Trachea: No tracheal deviation.   Cardiovascular:      Rate and Rhythm: Normal rate and regular rhythm.      Heart sounds: Normal heart sounds. No murmur. No friction rub.   Pulmonary:      Effort: Pulmonary effort is normal. No respiratory distress.      Breath sounds: Normal breath sounds. No stridor. No wheezing or rales.   Abdominal:      General: Bowel sounds are normal.      Palpations: Abdomen is soft. There is no mass.      Tenderness: There is no tenderness. There is no guarding.      Hernia: No hernia is present.   Genitourinary:     Comments: Deferred per patient preference  Musculoskeletal: Normal range of motion.         General: No tenderness or deformity.   Skin:     Findings: No rash.   Neurological:      Mental Status: He is alert and oriented to person, place, and time.      Cranial Nerves: No cranial nerve deficit.      Motor: No abnormal muscle tone.      Deep Tendon Reflexes: Reflexes normal.
A68	SectionSkipType T220 physical_exam
T222	SectionSkip 3036 3178	Patient's allergies, medications, past medical, surgical, family and social histories were reviewed and no interval updates necessary or noted
A70	SectionSkipType T222 allergies
A16	NegationModalityVal T167 affirmed
A71	TreatmentTypeVal T167 others
A72	TreatmentCategory T167 Others
A73	RadPathResultVal T167 InitialCancerDiagnosis
R9	ResultOfTest Desc:T167 Test:T166	
T223	Site 985 988	SMA
T224	Site 993 1008	mesenteric root
T225	Site 1041 1069	SMV-portal venous confluence
R45	SiteOf Arg1:T225 Arg2:T173	
R46	SiteOf Arg1:T224 Arg2:T173	
R47	SiteOf Arg1:T223 Arg2:T173	
R48	HappensAtOnDuring Arg1:T191 Arg2:T192	
T226	TreatmentType 1474 1483	treatment
A74	NegationModalityVal T226 negated
A76	TreatmentContinuityVal T33 started
A77	TreatmentTypeVal T33 maintenance
A78	TreatmentIntentVal T33 palliative
T227	Datetime 1545 1554	07/31/18:
T228	Datetime 1573 1581	08/14/18
T229	Datetime 1589 1597	08/28/18
T230	Datetime 1605 1613	09/11/18
T231	Datetime 1621 1629	09/22/18
T232	Datetime 1717 1725	09/25/18
T233	Datetime 1770 1778	10/09/18
T234	Datetime 1786 1794	10/23/18
T235	Datetime 1802 1810	11/06/18
T236	Datetime 1834 1842	11/17/18
T237	Cycles 1555 1559	C1D1
T238	Cycles 1583 1587	C2D1
T239	Cycles 1599 1603	C3D1
T240	Cycles 1615 1619	C4D1
T241	Cycles 1727 1731	C5D1
T242	Cycles 1780 1784	C6D1
T243	Cycles 1796 1800	C7D1
T244	Cycles 1811 1815	C8D1
T245	MedicationRegimen 1560 1570	FOLFIRINOX
A75	TreatmentContinuityVal T245 continuing
A79	TreatmentTypeVal T245 maintenance
A80	TreatmentIntentVal T245 palliative
R49	TreatmentDesc Therapy:T237 Desc:T245	
R50	TreatmentDesc Therapy:T238 Desc:T245	
R51	TreatmentDesc Therapy:T239 Desc:T245	
R52	TreatmentDesc Therapy:T240 Desc:T245	
R53	TreatmentDesc Therapy:T241 Desc:T245	
R54	TreatmentDesc Therapy:T242 Desc:T245	
R55	TreatmentDesc Therapy:T243 Desc:T245	
R56	TreatmentDesc Therapy:T244 Desc:T245	
R57	HappensAtOnDuring Arg1:T228 Arg2:T238	
R58	HappensAtOnDuring Arg1:T229 Arg2:T239	
R59	HappensAtOnDuring Arg1:T230 Arg2:T240	
T246	Radiology 1631 1637	CT CAP
A81	IntentVal T246 TreatmentAssessment
T247	Radiology 1844 1846	CT
A82	IntentVal T247 TreatmentAssessment
T248	DiseaseState 1854 1868	stable disease
A83	DiseaseStateVal T248 stability
T249	DiseaseState 1638 1662	slight interval decrease
A84	DiseaseStateVal T249 others
R60	TestOrProcedureReveals Test:T246 Desc:T249	
T250	RadPathResult 1654 1678	decrease in size of mass
A85	NegationModalityVal T250 affirmed
A86	RadPathResultVal T250 TreatmentResponse
R61	ResultOfTest Desc:T250 Test:T246	
R62	HappensAtOnDuring Arg1:T232 Arg2:T241	
T251	TreatmentDoseModification 1744 1756	dose reduced
T252	MedicationName 1733 1743	Irinotecan
A87	TreatmentContinuityVal T252 continuing
A88	TreatmentTypeVal T252 maintenance
A89	TreatmentIntentVal T252 palliative
A90	TreatmentCategory T252 AntiNeoPlastics
R63	TreatmentDesc Therapy:T251 Desc:T252	
T253	Symptom 1761 1768	fatigue
A91	IsPresentOnFirstCancerDiagnosis T253 no
A92	IsCausedByDiagnosedCancer T253 no
A93	ContinuityVal T253 worsening
R64	ConditionOrTreatmentCausesProblem Treatment:T245 Prob:T253	
T254	TreatmentType 1900 1912	chemotherapy
A94	TreatmentContinuityVal T254 discontinued_early
A95	TreatmentTypeVal T254 maintenance
A96	TreatmentIntentVal T254 palliative
A97	NegationModalityVal T44 negated
A98	NegationModalityVal T45 negated
A99	NegationModalityVal T46 negated
A100	NegationModalityVal T47 negated
A101	NegationModalityVal T48 negated
A102	NegationModalityVal T49 negated
A103	NegationModalityVal T50 negated
A104	NegationModalityVal T51 negated
A105	NegationModalityVal T52 negated
A106	NegationModalityVal T53 negated
A107	NegationModalityVal T54 negated
A108	NegationModalityVal T55 negated
A109	NegationModalityVal T56 negated
A110	NegationModalityVal T58 negated
A111	NegationModalityVal T59 negated
A112	NegationModalityVal T60 negated
A113	NegationModalityVal T61 negated
A114	NegationModalityVal T62 negated
A115	NegationModalityVal T63 negated
A116	NegationModalityVal T64 negated
A117	NegationModalityVal T65 negated
A118	NegationModalityVal T66 negated
A119	NegationModalityVal T67 negated
A120	NegationModalityVal T68 negated
A121	NegationModalityVal T69 negated
A122	NegationModalityVal T70 negated
A123	NegationModalityVal T71 negated
A124	NegationModalityVal T72 negated
A125	NegationModalityVal T73 negated
A126	NegationModalityVal T74 negated
A127	NegationModalityVal T75 negated
A128	NegationModalityVal T76 negated
T221	PerformanceStatus 3645 3646	0
A69	PerformanceStatusType T221 ECOG
T255	SectionSkip 5114 5786	Lab Results   Component Value Date    WBC Count 6.0 05/07/2019    Hemoglobin 13.8 05/07/2019    Hematocrit 40.4 (L) 05/07/2019    Platelet Count 151 05/07/2019    Neutrophil Absolute Count 3.74 05/07/2019    Alanine transaminase 39 05/07/2019    Aspartate transaminase 44 (H) 05/07/2019    Alkaline Phosphatase 80 05/07/2019    Bilirubin, Total 1.2 05/07/2019    Int'l Normaliz Ratio 1.1 07/25/2018    Carcinoembryonic Antigen 15.1 (H) 12/23/2018    Carcinoembryonic Antigen 33.9 (H) 11/06/2018    Carcinoembryonic Antigen 37.6 (H) 10/23/2018    Cancer Antigen 19-9 289 (H) 12/23/2018    Cancer Antigen 19-9 2,878 (H) 11/06/2018    Cancer Antigen 19-9 6,428 (H) 10/23/2018
A129	SectionSkipType T255 laboratory
T256	GenomicTest 5811 5830	Foundation Medicine
A130	IntentVal T256 diagnosis
A131	GenomicTestType T256 Somatic
T257	GenomicTestResult 5842 5851	MS-Stable
A132	GenomicTestType T257 Somatic
R65	ResultOfTest Desc:T257 Test:T256	
T258	GenomicTestResult 5881 5890	5 Muts/Mb
A133	GenomicTestType T258 Somatic
T259	GenomicTestResult 5892 5901	KRAS G12V
A134	GenomicTestType T259 Somatic
T260	GenomicTestResult 5903 5913	TP53 I195F
A135	GenomicTestType T260 Somatic
T261	GenomicTestResult 5922 5931	CBL P782L
A136	GenomicTestType T261 Somatic
T262	GenomicTestResult 5933 5946	CDKN2A/B loss
A137	GenomicTestType T262 Somatic
T263	GenomicTestResult 5948 5959	MTOR  R2109
A138	GenomicTestType T263 Somatic
T264	GenomicTestResult 5961 5980	NKX2-1 G239_G241del
A139	GenomicTestType T264 Somatic
T265	GenomicTestResult 5982 5995	PDGFRB  V523M
A140	GenomicTestType T265 Somatic
T266	GenomicTestResult 5997 6011	PIK3C2G  T488A
A141	GenomicTestType T266 Somatic
T267	GenomicTestResult 6013 6027	TNFAIP3  P752S
A142	GenomicTestType T267 Somatic
T268	Datetime 6394 6398	June
T269	Datetime 6454 6463	June 2019
R66	TestOrProcedureReveals Test:T169 Desc:T175	
R67	HappensAtOnDuring Arg1:T237 Arg2:T227	
R68	HappensAtOnDuring Arg1:T246 Arg2:T231	
R69	HappensAtOnDuring Arg1:T242 Arg2:T233	
R70	HappensAtOnDuring Arg1:T243 Arg2:T234	
R71	HappensAtOnDuring Arg1:T244 Arg2:T235	
R72	HappensAtOnDuring Arg1:T247 Arg2:T236	
R73	HappensAfter Arg1:T254 Arg2:T236	
R74	HappensAfter Arg1:T33 Arg2:T199	
T270	ap_end 6459 6463	2019
T271	ap_start 6080 6090	Assessment
T272	hpi_end 2103 2114	increasing.
T273	hpi_start 33 40	Patient
T274	hpi_start 5791 5800	Molecular
T275	hpi_end 6022 6027	P752S
R75	BeginsOnOrAt Arg1:T245 Arg2:T227	
R76	HappensAtOnDuring Arg1:T251 Arg2:T232	
R77	EndsOnOrAt Arg1:T217 Arg2:T214	
